ProductAvailABIlity:InStock(deliverywithin2-3businessdays,noextrachargefordrop-shipping).
Ordering:ToplaceanorderviacreditcardorPOuseAddtoCartbutton(creatinganaccountisnotrequired).
TransfectionReagentfor ASPC-1Cells(PancreaticBetaCells,CRL-1682)
TransfectionEfficiency:
Reagentexhibitsatleast70%transfectionefficiencyofsiRNAdelivery.Transfectionefficiencywasdeterminedby qRT-PCR.
TransfectionProtocolandMSDS:
DownloadAltogenBiosystemsASPC-1TransfectionProtocol:[PDF]
DownloadMSDS:[PDF]
ASPC-1 CellLine:
Pancreaticcancerisoneofthemostchallengingcancerstodiagnose,astherenospecificandreliablescreeningtestsonthemarketthatcanhelpdetectthediseaseinearlystages.AccordingtotheAmericanCancerSociety,ifcaughtinitsearlystages,the5-yearsurvivalrateis27%,butifcancermetastasizesthenthisnumbergoesdownto11%.TheAsPC-1celllinecomprisingpancreaticbetacellsandisaninvaluabletoolforpancreaticcancerresearchaswellascommonlyemployedforstudyinghumaninfectionsrelatedtothepancreas.TheAsPC-1celllinewasreestablishedvianudemousexenograftsinitiatedwithcellsfromtheascitesofa62-year-oldCaucasianwomanwithmetastaticpancreaticadenocarcinoma.Thereestablishedepithelialcellsretainedtheiroriginalmorphology.Thistumorrepresentsanewmodelforhumanpancreaticcancer.AsPC-1cellsareusedinstudiesseekingpossibletreatmentsforpancreaticcancer,whichhasafive-yearsurvivalrateoflessthanonepercent.Forexamples,researchhasshownthattheplantalkaloidsanguinarineinducedapoptosisofAsPC-1cells.Inanotherstudy,immunoprecipitationandELISAusinghumanpancreaticcancercellsrevealedthepresenceofhighlevelsofDcR3proteininAsPC-1cells.ReducingendogenousDcR3levelsincreasesFasL-inducedapoptosisofhumanpancreaticcancercells.Anotherintriguingstudyindicatedthatdeuteriumoxide(D2O),alsocalledheavywater,inducedapoptosisofAsPC-1,andisconsideredapossiblefuturetreatmentagainstAsPC-1.
Data:
Figure1.CyclophilinBsilencingefficiencywasdeterminedbyqRT-PCRintheAsPC-1cellstransfectedbyCyclophilinBsiRNAornon-silencingsiRNAcontrolfollowingtherecommendedtransfectionprotocol.CyclophilinmRNAexpressionlevelsweremeasured48hourspost-transfection.18SrRNAlevelswereusedtonormalizetheCyclophilinBdata.Valuesarenormalizedtountreatedsample.Dataarepresentedasmeans±SD(n=3).
Figure2.ProteinexpressionofCyclophilinBinAsPC-1cells.DNAplasmidexpressingCyclophilinBorsiRNAtargetingCyclophilinBweretransfectedintoAsPC-1cellsfollowingAltogenBiosystemstransfectionprotocol.At72hourspost-transfectionthecellswereanalyzedbyWesternBlotforproteinexpressionlevels(normalizedbytotalprotein,10µgoftotalproteinloadedpereachwell).Untreatedcellsusedasanegativecontrol.
Selected invivo transfectionproductcitations(ALTOGEN® INVIVO TransfectionKits usedinthefollowingpublications):
AltogenBiosystems:
AltogenBiosystemsprovidespreoptimizedtransfectionproductsforlifescienceresearchapplications.Transfectionprotocolsareoptimizedforindividualcancercelllines.AltogenBiosystemsdevelopedtwotypesofinvivodeliverykitsforanimalresearch:Tissue-targetedreagents(deliverytoliver,pancreas,andkidneytissues),andbroadrangeinvivodeliveryreagents(PEG-Liposome,Nanoparticle-based,Lipid-based,andPolymer-basedkits).Advancedformulationofreagentsandoptimizedtransfectionprotocolsprovideefficientintracellulardeliveryofproteins,DNA,RNA,andanyothernegativelychargedmoleculesinvitroandinvivo.Readmore abouttransfectiontechnologyatAltogen’sTransfectionResource.
AltogenLabsResearchServices:
AltogenLabsprovidesGLP-compliantcontractresearchstudiesforpre-clinicalresearch,INDapplications,anddrugdevelopment.BiologyCROservices include:Xenograftmodels(30+),developmentofstablecelllines,ELISAassaydevelopment,cell-basedandtissuetargetedRNAistudies,safetypharm/toxassays,andotherstudies(visitAltogenLabs.com).
VolumeOptions:
Altogen Biosystems是一家开发和制造用于生命科学研究,药物发现和开发的转染试剂盒的生物技术公司。转染试剂盒针对特定癌细胞系和原代细胞培养进行了优化,可将生物分子有效递送到靶组织中。通过先进的试剂配方和优化的转染方案实现体外(癌细胞系)和体内(动物组织靶向试剂、癌细胞系)递送货物分子,包括质粒DNA,各种类型的RNA(mRNA,siRNA,shRNA,microRNA),蛋白质和小分子研究。
苏州蚂蚁淘代理Altogen Biosystems在中国的业务。Altogen Biosystems北京代理,Altogen Biosystems华东代理,Altogen Biosystems华北代理,Altogen Biosystems全国代理,Altogen Biosystems华南代理。